Anti-CD80 [IDEC-114 (Galiximab)]
Product Sizes
0.2 mg
£ POA
MBS488347-0.2MG
About this Product
- SKU:
- MBS488347
- Additional Names:
- T-lymphocyte activation antigen CD80; T-lymphocyte activation antigen CD80; T-lymphocyte activation antigen CD80; CD80 molecule; Activation B7-1 antigen; BB1; CTLA-4 counter-receptor B7.1; B7; CD_antigen: CD80; B7-1; T-lymphocyte activation antigen CD80; Activation B7-1 antigen; BB1; CTLA-4 counter-receptor B7.1; B7
- Application:
- Block/Inhibit/Neutralise, ELISA, FACS, Flow Cytometry, Immunohistochemistry, Immunoprecipitation, Western Blot
- translate.label.attr.clone:
- [IDEC-114]
- Clonality:
- Monoclonal
- Concentration:
- 1 mg/ml
- Isotype:
- IgG1, lambda
- Purity:
- Protein A Affinity Purified
- Reactivities:
- Human
- Shipping Conditions:
- Blue Ice
- Specificity:
- Galiximab is a primatized mAb which consists of human constant and primate (cynomolgus macaque) variable regions and binds specifically to CD80. CD80 is a surface glycoprotein and a member of the B7 family of costimulatory molecules. CD80 antigen regulates T cell activation (through interacting with CD28 or CD152) and is expressed transiently in antigen-presenting cells, T cells and normal B cells
- Storage Conditions:
- Please refer to datasheet
- Supplier:
- MyBioSource
- Type:
- Antibody: Monoclonal Antibody
- Manufacturer's Data Sheet:MBS488347
